Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-01-05
1997-08-19
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514538, 514539, 514562, 514563, 514567, 514 63, 514617, 514464, 560 40, 562439, 562446, 549435, 549444, 556419, C07C22936, C07C22930, C07C31760
Patent
active
056589433
ABSTRACT:
Novel antagonists of endothelin are described, as well as novel intermediates used in their preparation, methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, essential, renovascular, malignant and pulmonary hypertension, cerebral infarction, myocardial ischemia, cerebral ischemia, congestire heart failure and subarachnoid hemorrhage.
REFERENCES:
patent: 3714241 (1973-01-01), Grenda
patent: 3930017 (1975-12-01), Kummer et al.
patent: 4497964 (1985-02-01), Ojima et al.
patent: 5198548 (1993-03-01), Beylin et al.
patent: 5246943 (1993-09-01), Blankley et al.
Davies et al., CA 118:81342 (1993), registry No. 90656-96-5.
Nie et al., CA 116:255995 (1992), registry No. 141523-18-4.
Lavin et al., CA 114:75177 (1991), registry No. 131930-02-4.
Hansen et al., CA 102:149743 (1985), registry No. 94732-12-4.
Somack et al., CA 96:28824 (1982), registry Nos. 80248-16-4, 80248-17-5, 80248-20-0 and 80248-21-1.
Gosteli, CA 77:114271 (1972), registry No. 36943-43-8.
Kirby et al., CA 76:59149 (1972), registry No. 35175-72-5.
Mukherjee et al., CA 75:5371 (1971), registry No. 32299-75-5.
Matsuura et al., CA 72:44093 (1970), registry No. 24956-73-8.
Matsuura et al., CA 69:52461 (1968), registry No. 19103-40-3.
Block, CA 67:108980 (1967), registry Nos. 15962-67-1 and 15962-69-3.
S. Klutchko, et al., Bioorganic & Medicinal Chemistry Letters, 1994, 4:1, 57-62.
Berryman Kent Alan
Cheng Xue-Min
Doherty Annette Marian
Edmunds Jeremy John
Klutchko Sylvester
Anderson Elizabeth M.
Richter Johann
Stockton Laura L.
Warner-Lambert & Company
LandOfFree
Phenylalanine derivatives as endothelin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenylalanine derivatives as endothelin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylalanine derivatives as endothelin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1105223